Skip to Content

Therma Bright Inc TBRIF

Morningstar Rating
$0.01 0.00 (1.37%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TBRIF is trading at a 64% discount.
Price
$0.01
Fair Value
$9.68
Uncertainty
Extreme
1-Star Price
$2.66
5-Star Price
$5.59
Economic Moat
Hhd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TBRIF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.09
Bid/Ask
$0.01 / $0.02
Market Cap
$4.55 Mil
Volume/Avg
271,496 / 117,519

Key Statistics

Price/Earnings (Normalized)
Price/Sales
196.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Therma Bright Inc is a medical diagnostic and device technology company focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company’s initial proprietary technology delivers non-invasive and pain-free skincare. The company's products include AcuVid, InterceptCS, Benepod, Venowave, TheroZap, Inretio and others.TherOZap and InterceptCS. The InterceptCS system provides controlled topical heat, without the risk of burning the skin, which will naturally prevent cold sore outbreaks. The TherOZap thermal therapy reduces the inflammatory response, relieving the symptoms of pain, itch, and inflammation associated with bites and stings.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees

Valuation

Metric
TBRIF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
196.32
Price/Cash Flow
Price/Earnings
TBRIF

Financial Strength

Metric
TBRIF
Quick Ratio
0.02
Current Ratio
0.13
Interest Coverage
−280.12
Quick Ratio
TBRIF

Profitability

Metric
TBRIF
Return on Assets (Normalized)
−112.28%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−216.02%
Return on Assets
TBRIF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesCwknfp$207.2 Bil
SYK
Stryker CorpQmy$133.9 Bil
MDT
Medtronic PLCCgtr$111.5 Bil
BSX
Boston Scientific CorpFpzdcvw$97.5 Bil
EW
Edwards Lifesciences CorpDmpjkc$52.0 Bil
DXCM
DexCom IncQyjl$44.5 Bil
ZBH
Zimmer Biomet Holdings IncHxxn$25.9 Bil
ALGN
Align Technology IncGhfln$24.0 Bil
PHG
Koninklijke Philips NV ADRCclsj$18.3 Bil
SNN
Smith & Nephew PLC ADRPhrdx$12.4 Bil

Sponsor Center